» Articles » PMID: 27603367

The Association Between Maternal Hyperglycemia and Perinatal Outcomes in Gestational Diabetes Mellitus Patients: A Retrospective Cohort Study

Overview
Specialty General Medicine
Date 2016 Sep 8
PMID 27603367
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Pregnancies complicated by gestational diabetes mellitus (GDM) are associated with increased risks of adverse maternal and fetal outcomes. The risks of adverse pregnancy outcomes differ depending on the glucose values among GDM patients. For accurate and effective prenatal counseling, it is necessary to understand the relationship between different maternal hyperglycemia values and the severity of adverse outcomes. With this objective, this study reexamines the relationship between maternal hyperglycemia versus maternal and perinatal outcomes in GDM patients. For this study, maternal hyperglycemia was diagnosed using the 2-step diagnostic approach.Medical records of 3434 pregnant women, who received the 50-g glucose challenge test (GCT) between March 2001 and April 2013, were reviewed. As a result, 307 patients were diagnosed with GDM, and they were divided into 2 groups according to their fasting glucose levels. A total of 171 patients had normal fasting glucose level (<95 mg/dL), and 136 patients had abnormal fasting glucose level (≥95 mg/dL). The 50-g GCT results were subdivided by 20-unit increments (140-159, n = 123; 160-179, n = 84; 180-199, n = 50; and ≥200, n = 50), and the maternal and perinatal outcomes were compared against the normal 50-g GCT group (n = 307).Maternal fasting blood glucose (FBG) level showed clear association with adverse perinatal outcomes. The odds ratio (OR) of macrosomia was 6.72 (95% CI: 2.59-17.49, P < 0.001) between the 2 groups. The ORs of large for gestational age (LGA) and neonatal hypoglycemia were 3.75 (95% CI: 1.97-7.12, P < 0.001) and 1.65 (95% CI: 0.79-3.43, P  =  0.183), respectively. Also, the results of the 50-g GCT for each category showed strong association with increased risks of adverse perinatal outcomes compared to the normal 50-g GCT group. The OR of macrosomia (up to 20.31-fold), LGA (up to 6.15-fold), and neonatal hypoglycemia (up to 84.00-fold) increased with increasing 50-g GCT result.

Citing Articles

Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization.

Xia L, Fan L, Huang J, Zhao Y, Tian L, Chen H Reprod Biol Endocrinol. 2024; 22(1):149.

PMID: 39574097 PMC: 11580555. DOI: 10.1186/s12958-024-01313-8.


Neighborhood Environment and Poor Maternal Glycemic Control-Associated Complications of Gestational Diabetes Mellitus.

Thomas L, Jurkovitz C, Zhang Z, Fawcett M, Lenhard M AJPM Focus. 2024; 3(3):100201.

PMID: 38524098 PMC: 10958063. DOI: 10.1016/j.focus.2024.100201.


Maternal and Neonatal Outcomes of Pregnant Women with Abnormal 50 g Glucose Challenge Tests in Nakhon Si Thammarat, Thailand: A Retrospective Study.

Jaihow S, Phasuk N, Narkkul U, Pensuksan W, Scholand S, Punsawad C Int J Environ Res Public Health. 2023; 20(22).

PMID: 37998269 PMC: 10671579. DOI: 10.3390/ijerph20227038.


Obesity Is Associated With Higher Risk of Adverse Maternal and Neonatal Outcomes Than Supervised Gestational Diabetes.

Seo N, Lee Y, Kim Y, Sung J, Hur K, Choi S J Korean Med Sci. 2023; 38(33):e268.

PMID: 37605501 PMC: 10442500. DOI: 10.3346/jkms.2023.38.e268.


The relationship between pregnancy count and duration of breast-feeding with metabolic syndrome (Fasa Persian cohort study).

Zareei S, Behrasi F, Naghizadeh M, Talebzadeh F, Kharmandar A, Farjam M BMC Womens Health. 2023; 23(1):371.

PMID: 37443023 PMC: 10339557. DOI: 10.1186/s12905-023-02528-4.


References
1.
Jovanovic-Peterson L, Peterson C, Reed G, Metzger B, Mills J, Knopp R . Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1991; 164(1 Pt 1):103-11. DOI: 10.1016/0002-9378(91)90637-7. View

2.
Sacks D, Chen W, Wolde-Tsadik G, Buchanan T . Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Obstet Gynecol. 2003; 101(6):1197-203. DOI: 10.1016/s0029-7844(03)00049-8. View

3.
Kautzky-Willer A, Bancher-Todesca D, Birnbacher R . [Gestational diabetes mellitus]. Acta Med Austriaca. 2005; 31(5):182-4. View

4.
. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ. 2008; 336(7646):714-7. PMC: 2276266. DOI: 10.1136/bmj.39505.641273.AD. View

5.
Zawiejska A, Wender-Ozegowska E, Radzicka S, Brazert J . Maternal hyperglycemia according to IADPSG criteria as a predictor of perinatal complications in women with gestational diabetes: a retrospective observational study. J Matern Fetal Neonatal Med. 2013; 27(15):1526-30. DOI: 10.3109/14767058.2013.863866. View